
Current role and future direction of osimertinib in epidermal growth factor receptor-mutant non-small cell lung cancer
Author(s) -
ByeongHo Jeong,
SangWon Um
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.12.37
Subject(s) - osimertinib , t790m , epidermal growth factor receptor , lung cancer , medicine , cancer research , mutant , tyrosine kinase , epidermal growth factor , receptor , oncology , biology , gefitinib , erlotinib , genetics , gene